Covid-19 Innovation Challenges by Innoget posted this Technology CallSeeking nurse-led ideas from nurses and nursing students around the world focused on improving COVID-19 patient careNurses have always been critical partners on the frontlines of care, and the backbone of our healthcare system. The COVID-19 pandemic has raised new challenges for nurses and health workers and brought into focus the obstacles that they face around the world, every day. The power of nurse-led innovation and know-how may be more critical than ever when developing potential solutions amid a global crisis. With extensive patient experience, nurses’ ideas have the potential to profoundly improve human health. In connection with our overall commitment to supporting frontline healthcare workers amid the COVID-19 pandemic, Johnson & Johnson is proud to continue the Nurses Innovate QuickFire Challenges series with a new challenge inspired by the NurseHack4Health: COVID-19 Virtual Hackathon where over 500 nurses, healthcare professionals, and tech enthusiasts convened virtually to help ideate potential solutions for COVID-19 health challenges. This QuickFire Challenge is open to all nurse innovators, and aims to help nurture early-stage ideas from the frontlines of COVID-19 by celebrating, supporting, & mentoring the nurse innovators behind them. Introducing the Johnson & Johnson Nurses Innovate QuickFire Challenge in COVID-19 Patient Care together with the American Organization for Nursing LeadershipTM (AONL) and the Society of Nurse Scientists, Innovators, Entrepreneurs, & Leaders (SONSIEL). Nurses from around the world are invited to submit ideas aiming to improve COVID-19 patient care. The nurse innovators with the best idea(s) will receive up to $100,000 in grant funding, mentoring from experts across the Johnson & Johnson Family of Companies, and access to the Johnson & Johnson Innovation – JLABS ecosystem to help bring their ideas to life. As innovators on the frontlines of healthcare, nurses have the power to profoundly change lives. Johnson & Johnson has the scale, resources and know-how to help move them forward. Put these two together, and that changes everything. We have never stopped and never will stop advocating for, elevating and empowering nurses as innovative, critical leaders on the frontline. Learn more about nurses who innovate, and the commitment Johnson & Johnson has made to nurses over the past 120 years at https://nursing.jnj.com/our-commitment. Learn more about how we are supporting front line health workers amid the COVID-19 Pandemic
PepsiCo posted this Technology CallSeeking moisture barrier for bio-based filmsWe have been working on bio-based/biodegradable flexible films for food packaging to help achieve our sustainability goals of having 100% RCB compliance for our packages as well as 20% reduction in GHG by 2030. While flexible package is a very sustainable option from a material use point of view, the multi-layer multi-material structures are not conducive for recycling and mostly end up in the landfill or as litter. While the biodegradable films help us with the end of life issues by designing for managed waste infrastructures like composting and anaerobic digestion, it cannot be at the expense of performance compromises such as reduced shelf stability. Oxygen barrier is not a problem with these films but achieving the very high moisture barrier required for packaging dry foods (< 0.3 g/m2/day under tropical conditions of 38C/90% RH) has been a challenge. We understand that metallization will be needed to achieve the high moisture barrier requirements, but even with metallization we have not been able to reach this barrier with bio-based films. Also, it is important to maintain this barrier under forming conditions in the VFFS process of bag-making. We are looking for novel resins that can be co-extruded with our core resins to form a skin layer with high functionality that can anchor metal to film or highly functional coatings which would serve the same purpose. Inherently high barrier coatings that can be applied as primer coating or top coating over metal could also be a solution.
PepsiCo posted this Technology CallSeeking revolutionary plant protein sourcesThe food and beverage market currently has significant growing demand for protein rich or protein enriched products. The trend is clearly demonstrated in the recent success of Greek style yogurt and the growing demand plant-based food and beverages. The challenge with protein additions at levels at which claims can be made is that the protein adversely impacts the texture/mouth feel, taste, color, of the product. Therefore, consumer perceptions of the product suffer. The goal is to locate novel new proteins that do not suffer from these drawbacks and/or unique extraction methods to mitigate/minimize their magnitude. Goal is to get to a claimable content of protein relevant to each category.
PepsiCo posted this Technology CallSeeking novel proposals to incorporate pea protein concentrate into low pH beveragesHumans have cultivated and eaten peas (Pisum sativum) for millennia. Modern consumers are looking to the seed as a promising protein source – it is rich in proteins which can be isolated to make pea protein concentrates (PPC). While PPC are available in many forms and products, little or no research has been done to understand its behavior in low pH solution or model systems. As a result, food producers have encountered difficulties incorporating PPC into acidic products, such as fruit juices. The goal of this project is to identify pea protein concentrates that are suitable for usage in low pH systems or to find technologies capable of processing PPC so that they may be used in low pH environments.
Covid-19 Innovation Challenges by Innoget posted this Technology CallSeeking candidates to apply to the LifeArc COVID-19 FundLifeArc has made available an initial £10M for the identification of therapeutics that can be rapidly deployed to treat COVID-19. The aim is to run trials in patients during the current epidemic. It is anticipated that applications will be for funding to repurpose one or more drugs that are generic, already licensed, or are in late stage development for another indication.